Moderna (MRNA) President Stephen Hoge sold approximately $17.01 million worth of company stock on October 14-15, following option exercises. The transactions were executed under a pre-arranged Rule 10b5-1 trading plan .
Key details:
- Sale Value: $17.01 million
- Shares Sold: 78,369 shares at weighted average prices between $213.47 and $220.72
- Option Exercise: Hoge also acquired 152,905 shares via option exercises at $12.21 per share
- Context: MRNA stock has returned 738% over the past year and is currently trading at $218.01. InvestingPro analysis suggests the stock appears overvalued relative to its Fair Value .
Moderna president Stephen Hoge sells $17m in stock
INVESTING.COMOct 17, 8:16 AM UTC
0
